Post-ICSI oocyte degeneration inflates the conventional blastocyst utilization rate: degeneration-penalized and MII-anchored denominator corrections
Journal of Assisted Reproduction and Genetics · 14.11.2026
DOI: 10.1007/s10815-026-04075-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, online erschienen am 14.11.2026. Verfasst von Emrah Onder und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Business, Department of Quantitative Methods, Istanbul University, Istanbul, Turkey. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Purpose
Conventional IVF laboratory key performance indicators (KPIs) are reported as single (“sole”) ratios, with the denominator excluding mature oocytes lost during the procedure. We tested whether the blastocyst utilization rate overstates measured performance by excluding post-ICSI oocyte degeneration from its denominator, and we developed two complementary corrections that return degeneration to the denominator.
Methods
Retrospective analysis of a single pooled ICSI cohort of 7,216 cycles and 56,349 MII oocytes. Against the conventional blastocyst utilization rate (BUR = Frozen/2PN), we defined: a degeneration-penalized BUR (DP-BUR) that adds degenerated oocytes to the denominator—additive, Frozen/(2PN + ATR), and multiplicative, (Frozen/2PN) × (1 − ATR/MII)—and a true BUR (TBUR = Frozen/MII) anchored to all mature oocytes. ATR denotes post-ICSI degenerated oocytes. We directly measured degeneration in 1,552 cycles (21.5%) and modeled it within the documented 1–5% institutional range in the remainder; a sensitivity analysis was restricted to the directly measured cycles. We stratified degeneration as < 5% versus ≥ 5%. Each metric was compared against the 40% competence benchmark defined for conventional BUR—applied to the corrected metrics to quantify recalibration, not as a validated threshold—and we counted how many operators (anonymized analysis units) changed benchmark status across metrics; these metrics are not proposed as tools to attribute error to individual operators.
Results
Conventional BUR was 41.9; DP-BUR was 40.2 (additive) and 40.5 (multiplicative); TBUR was 32.8—bracketing the correction, with DP-BUR attributing the gap to degeneration alone (+ 4% over the degeneration-penalized value) and TBUR to all mature-oocyte attrition (+ 28%). In the sensitivity analysis restricted to cycles with directly measured degeneration (1,552 cycles; 14,433 MII; degeneration 6.5%), the gap persisted and widened: conventional BUR 53.6 versus DP-BUR 49.6 (additive) and TBUR 43.0 (+ 8.2% and + 24.8%, respectively). The corrections were degeneration-dependent and, for DP-BUR, degeneration-specific: from < 5% to ≥ 5% degeneration, DP-BUR fell from 54.4% to 42.7% while conventional BUR barely moved (54.6% → 52.0%), so DP-BUR is essentially flat where degeneration is low and drops only where it is high; TBUR fell from 46.1% to 38.4%. Against the 40% benchmark, conventional BUR passed 24 of 38 operators, DP-BUR passed 17 (7 flipped from pass to fail), and TBUR passed 7 (17 flipped). Both conventional BUR and TBUR scored two cycles with identical mature-oocyte and fertilization counts, but different degeneration counts, and DP-BUR separated them.
Conclusions
Conventional blastocyst utilization overstates measured performance because it excludes post-ICSI degeneration from its denominator. A degeneration-penalized denominator (DP-BUR, for which we recommend the additive form for practice) isolates the degeneration-specific component of oocyte attrition, while an MII-anchored denominator (TBUR) reports total usable yield from the mature oocytes retrieved and is best read as a cohort-level yield measure. Under both corrections, benchmark classifications changed for a substantial fraction of operators. These are denominator (accounting) corrections; they have not yet been validated against implantation, live birth, or cumulative live birth, and metric-specific reference ranges should be established before using the corrected indices for competency assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Business, Department of Quantitative Methods, Istanbul University, Istanbul, Turkey.
- Bahçeci Sağlık Grubu, Istanbul, Turkey.
- Department of Pharmacy Management, Medipol University, Istanbul, Turkey.
- Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, New Haven, United States.
- IVF Center, Istanbul IVF and Women's Health Center, Istanbul, Turkey.
- Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, New Haven, United States. murat.basar@yale.edu.
ORCID-Profile: Tuba Duzcu, Murat Basar
Zitieren
APA
Onder, E., Olcay, I. O., Duzcu, T., Bahceci, M., Arici, A., Duzcu, O., & Basar, M. (2026). Post-ICSI oocyte degeneration inflates the conventional blastocyst utilization rate: degeneration-penalized and MII-anchored denominator corrections. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-026-04075-x
Vancouver
Onder E, Olcay IO, Duzcu T, Bahceci M, Arici A, Duzcu O, et al. Post-ICSI oocyte degeneration inflates the conventional blastocyst utilization rate: degeneration-penalized and MII-anchored denominator corrections. Journal of Assisted Reproduction and Genetics. 2026. doi:10.1007/s10815-026-04075-x
BibTeX
@article{Onder2026,
author = {Onder, Emrah and Olcay, Ibrahim Orcun and Duzcu, Tuba and Bahceci, Mustafa and Arici, Aydin and Duzcu, Ozcan and Basar, Murat},
title = {Post-ICSI oocyte degeneration inflates the conventional blastocyst utilization rate: degeneration-penalized and MII-anchored denominator corrections},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2026},
doi = {10.1007/s10815-026-04075-x}
}
EUVIMED